Jefferies Financial Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Jefferies Financial Group's AMLX Position: Q3 2026 in Review
Jefferies Financial Group opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 2,500 shares worth $72.8K. The stake represents ﹤0.01% of the portfolio and ranks #1203 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in AMLX as recently as Q1 2025.
Jefferies Financial Group first reported a position in AMLX in Q3 2024 and has held it in 4 quarters since. The position peaked at $175K in Q4 2024. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Jefferies Financial Group held 2,500 shares of Amylyx Pharmaceuticals worth $72.8K as of Q3 2026.
- Amylyx Pharmaceuticals was a new Jefferies Financial Group position in Q3 2026.
- Amylyx Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1203 holding.
- Jefferies Financial Group first reported a position in Amylyx Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
- Jefferies Financial Group's Amylyx Pharmaceuticals position peaked at $175K in Q4 2024.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.